Back

Kura launches Caspian with $50 million financing for menin strategy

Verifying
  • Kura Oncology launched Caspian Therapeutics alongside a $50 million financing.
  • KO-7246 will advance toward diabetes proof-of-concept and IND-enabling development.
  • Kura will retain approximately half of Caspian and board representation.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.